Search International and National Patent Collections

1. (WO2018083204) BISPECIFIC ANTIBODY AGAINST BCMA AND CD3 AND AN IMMUNOLOGICAL DRUG FOR COMBINED USE IN TREATING MULTIPLE MYELOMA

Pub. No.:    WO/2018/083204    International Application No.:    PCT/EP2017/078109
Publication Date: Sat May 12 01:59:59 CEST 2018 International Filing Date: Fri Nov 03 00:59:59 CET 2017
IPC: C07K 16/28
C07K 16/46
A61K 39/00
Applicants: ENGMAB SÀRL
Inventors: VU, Minh Diem
STREIN, Klaus
PAIVA, Bruno David Lourenço
SAN MIGUEL IZQUIERDO, Jesús Fernando
Title: BISPECIFIC ANTIBODY AGAINST BCMA AND CD3 AND AN IMMUNOLOGICAL DRUG FOR COMBINED USE IN TREATING MULTIPLE MYELOMA
Abstract:
The invention relates to a bispecific antibody specifically binding to human B cell maturation antigen (BCMA) and to human CD3ɛ (CD3) together with an immunotherapeutic drug for combined use in treating multiple myeloma..